For study participants treated with tirzepatide (5 mg, 10 mg and 15 mg, respectively), nausea (11.9 percent, 15.9 percent, 22.2 percent), diarrhea (12.2 percent, 19.5 percent, 20.4 percent) and vomiting (4.9 percent, 8.2 percent, 8.3 percent) were more frequently experienced compared to insulin glargine (1.6 percent [nausea], 3.2 percent [diarrhea], 1.1 percent [vomiting])
The SmPC advises appropriate retinal screening and monitoring, particularly if HbA1c reductions are substantial
Containing sterile water with a small amount of benzyl alcohol as a preservative, BAC Water is designed to help inhibit bacterial growth after opening, making it suitable for multiple withdrawals from the same vial
Table 1 Clinical characteristics of pregnancy by FT4 quartile